Xylocaine Injection, Solution
Product Images NDC 85766-190

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Xylocaine (NDC 85766-190). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sportpharm Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (Label)

Packaging label for Xylocaine (lidocaine HCl and epinephrine injection, USP) 1% injection solution relabeled for Sportpharm. The label includes two versions: one for NDC 85766-190-25 with a quantity of 25 and 25 x 20 mL multiple dose vials, and one for NDC 85766-190-01 with a quantity of 1 and a single 20 mL multiple dose vial. Distributed by Fresenius Kabi USA, LLC, with batch and expiration fields blank, and storage instructions detailed.*

FDA Label Image

Structure 1 (Xyl01 0002 01)

Chemical structure diagram of Lidocaine Hydrochloride is depicted, showing its molecular formula including a benzene ring with methyl groups, an amide linkage, and a diethylamino group bound to hydrochloride.*

FDA Label Image

Structure 2 (Xyl01 0002 02)

Chemical structure diagram of Lidocaine Hydrochloride, the active ingredient in Xylocaine injection solution, showing molecular bonds and functional groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.